Conference Date & Venue
InterContinental Houston
Support Construction of Binaytara's Cancer Hospital in Nepal
Event Description
The CME-accredited Best of Oncology 2026, Houston is designed to equip healthcare professionals with the most impactful, practice-changing updates and the latest advances across hematology and oncology. This comprehensive conference delivers a curated synthesis of high-impact clinical data in solid tumors and hematologic malignancies, with a focus on translating emerging evidence into real-world clinical practice.
Through a dynamic educational format that includes expert-led didactic lectures, case-based presentations, panel discussions, and interactive Q&A sessions, participants will gain practical insights into evolving standards of care, novel therapeutics, and precision medicine approaches. Faculty will distill key clinical trial results, guideline updates, and therapeutic innovations, emphasizing how new evidence may influence treatment selection, sequencing, and patient management.
Designed for a multidisciplinary audience, this program emphasizes a patient-centered approach to cancer care, addressing real-world challenges such as treatment-related toxicities, resistance mechanisms, and disparities in access to care. The activity aims to enhance clinician competence, improve performance, and support optimal patient outcomes.
CME credits are available, and participants may earn Maintenance of Certification (MOC) points, where applicable.
Target Audience
- Medical Oncologists
- Surgical Oncologists
- Radiation Oncologists
- Gynecological Oncologists
- Oncology Fellows
- Oncology Nurses
- Nurse Practitioners
- Physician Assistants
- Oncology Pharmacists
Contact Us
Phone: 425-361-0029
Email: sponsorships@binaytara.org
About Binaytara
Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.
As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.
As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.
We invite companies interested in improving equitable access to cancer care to support our efforts.